(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

T-ACEGEL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

T-ACEGEL

ST13

US500000090819587

Class

5

Filing

90819587

Registration

7306959

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

41

Latest update

05/27/2025

Classification

Registered

Trademark type

Combined

Nice classes

5

Filing date

07/09/2021

Registration date

02/13/2024

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/13/2024

Last transaction

05/27/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Supplemental Register

Drawing code

5

Owner type

03

Owner location

Tainan City, TW

Examiner

JAGDEO, KARA

Current location

Historical data usage

Mark description

The mark consists of the term "T-ACEGEL" in stylized format.

Holders and representatives

Holders

T-ACE Medical Co., Ltd.

Representatives

M. Scott Alprin ALPRIN LAW OFFICES, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Diagnostic reagents and contrast media for medical use; Medicines for human purposesmedicines for treating cancer; Pectin for pharmaceutical purposes; Colloid injections in the nature of sodium alginate and ion solutions for medical purposesnot including radioactive substancesthyroid hormone preparationspara-thyroid hormone preparations; Pharmaceutical preparations for the detectiondiagnosismonitoring and treatment of cancer

Publications

History of USPTO decisions and trademark events.

41 publications found

NURC

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

05/27/2025

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

05/02/2025

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

04/29/2025

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

04/18/2025

PRAM

POST REGISTRATION ACTION MAILED - SEC. 7

01/15/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/30/2024

ES7R

TEAS SECTION 7 REQUEST RECEIVED

06/24/2024

NRCS

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/13/2024

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

02/13/2024

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

08/23/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

08/21/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/21/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

08/21/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/21/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/19/2023

GNRT

NON-FINAL ACTION E-MAILED

05/19/2023

CNRT

NON-FINAL ACTION WRITTEN

05/19/2023

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

05/16/2023

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

05/02/2023

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/14/2023

ALIE

ASSIGNED TO LIE

04/10/2023

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

03/27/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

03/23/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/23/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

03/23/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/23/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/03/2023

GNRT

NON-FINAL ACTION E-MAILED

01/03/2023

CNRT

NON-FINAL ACTION WRITTEN

01/03/2023

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

11/21/2022

GNFR

FINAL REFUSAL E-MAILED

11/21/2022

CNFR

FINAL REFUSAL WRITTEN

11/21/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/12/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/11/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/11/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/12/2022

GNRT

NON-FINAL ACTION E-MAILED

04/12/2022

CNRT

NON-FINAL ACTION WRITTEN

04/12/2022

DOCK

ASSIGNED TO EXAMINER

03/29/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/16/2021

NWAP

NEW APPLICATION ENTERED

07/13/2021

Continuous trademark protection

Get notified about every new filing that threatens T-ACEGEL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.